Confident Investing Starts With TipRanks Premium

Get 55% Off
TipRanks
Go Ultimate55% OFF

Globus Medical (GMED) Stock Price & Analysis

GMED Stock Chart & Stats

$80.08$2.03(2.60%)
At close: 11:29 AM EST
$75$80$8510 Aug24 Aug8 Sep21 Sep5 Oct19 Oct2 Nov
Day’s Range
$77.60 - $80.42
52-Week Range
$59.51 - $101.40
Previous Close
$78.05
Volume
N/A
Average Volume (3M)
1.40M
Market Cap
$10.48B
Enterprise Value
$10.37B
Total Cash (Recent Filing)
$595.14M
Total Debt (Recent Filing)
$111.19M
Price to Earnings (P/E)
20.0
Beta
0.71
Next Earnings
Nov 05, 2026 (Est.)
EPS Estimate
1.2
Next Dividend Ex-Date
N/A
Dividend Yield
N/A

Bulls Say, Bears Say

Bulls Say

Broad Revenue Growth

Broad growth across the base business, U.S. and international spine supports durable demand for Globus Medical’s procedure-based portfolio. Continued expansion increases scale, strengthens commercial reach, and provides a foundation for recurring implant and consumables revenue over the next several quarters.

Margin Expansion

Improving gross and EBITDA margins indicate meaningful operating leverage and synergy capture following the NuVasive combination. The higher EPS outlook suggests management expects profitability gains to persist, supporting internal investment, cash generation, and stronger earnings power through 2026.

Strong Balance Sheet And Cash Flow

Very low leverage and substantial liquidity give Globus Medical flexibility to fund product development, commercial expansion, integration work, and capital returns without relying heavily on debt. Strong operating cash generation also improves resilience and supports sustained strategic investment.

Bears Say

Enabling Technology Revenue Pressure

The move toward lease and rental models reduces near-term capital-equipment sales and makes reported revenue conversion less predictable. Although deployments are growing, the business may need time for utilization and implant pull-through to offset weaker upfront cash sales.

Nevro Integration Drag

Nevro’s declining sales and ongoing integration changes create a durable execution burden within the broader portfolio. Until trial volumes recover and commercial operations stabilize, the business may face slower consolidated growth and continued management attention devoted to remediation.

Margin Volatility

Recent profitability recovery is encouraging, but the lower TTM gross margin and uneven historical results show that earnings power remains sensitive to product mix, pricing, and cost conditions. This volatility could limit the consistency of future margin expansion and cash conversion.

Globus Medical News

GMED FAQ

What was Globus Medical’s price range in the past 12 months?
Globus Medical lowest stock price was $59.51 and its highest was $101.40 in the past 12 months.
What is Globus Medical’s market cap?
Globus Medical’s market cap is $10.48B.
When is Globus Medical’s upcoming earnings report date?
Globus Medical’s next earnings report is estimated for Nov 05, 2026 (not yet confirmed), which is in 2 days.
How were Globus Medical’s earnings last quarter?
Globus Medical released its earnings results on Aug 06, 2026. The company reported $1.34 earnings per share for the quarter, beating the consensus estimate of $1.099 by $0.241.
Is Globus Medical overvalued?
According to Wall Street analysts Globus Medical’s price is currently Undervalued.
Does Globus Medical pay dividends?
Globus Medical does not currently pay dividends.
What is Globus Medical’s EPS estimate?
Globus Medical’s EPS estimate is 1.20.
How many shares outstanding does Globus Medical have?
Globus Medical has 111,831,820 shares outstanding.
What happened to Globus Medical’s price movement after its last earnings report?
Globus Medical reported an EPS of $1.34 in its last earnings report, beating expectations of $1.099. Following the earnings report the stock price went up 1.566%.
Which hedge fund is a major shareholder of Globus Medical?
Hedge funds hold Globus Medical shares: the largest hedge-fund position in Globus Medical is 71,885,099 shares, and hedge funds increased their holdings by 349.7K shares last quarter.
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology